万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>临床神经病学
您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>外周血管病

STROKE《卒中》 (官网投稿)

简介
  • 期刊简称STROKE
  • 参考译名《卒中》
  • 核心类别 SCIE(2023版), 高质量科技期刊(T1), 外文期刊,
  • IF影响因子
  • 自引率10.10%
  • 主要研究方向医学-CLINICAL NEUROLOGY临床神经病学;PERIPHERAL VASCULAR DISEASE外周血管病

主要研究方向:

等待设置主要研究方向
医学-CLINICAL NEUROLOGY临床神经病学;PERIPHERAL VASCULAR DISEASE外周血管病

STROKE《卒中》(月刊)。Stroke publishes reports of clinical and basic investigation of any aspect of the cerebral circulation and its diseases&...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、官网网址:https://www.ahajournals.org/journal/str

3、官网网址:

https://stroke-submit.aha-journals.org/cgi-bin/main.plex

4、官网邮箱:stroke@strokeahajournal.org(编辑部)

5、官网电话:+1-781-902-43955(编辑部)

6、期刊刊期:月刊,一个月出版一期。

2021423日星期五

                            

 

投稿须知

【官网信息】

 

 

New Submissions

To submit your manuscript online, please visit the journal's online manuscript submission site (http://stroke-submit.aha-journals.org), and follow the instructions for creating an author account and submitting a manuscript. Access can also be gained by visiting Stroke online at https://www.ahajournals.org/journal/str and selecting the Online Submissions button. If you have any questions about the online submission process, contact the Editorial Office by e-mail at stroke@strokeahajournal.org.

Basic and Translational Science

Research includes animal experiments, cell studies, biochemical, genetic and physiological investigations, and studies on the properties of drugs and materials. It also includes the development and improvement of analytical procedures, imaging procedures, gene sequencing, and the development of biometric procedures.

Authors are required to submit an online checklist requesting reporting of randomization procedures, blinding, a priori definition of inclusion and exclusion, etc. After selecting a Basic Science article type in the submission system, the form becomes available to complete as part of the submission process. If the manuscript is accepted, the form will be published as supplementary material. See "Reporting Standards for Preclinical Studies of Stroke Therapy" (Stroke. 2016;47:2435-2438) for more information.

Clinical Science

Clinical research involves interactions with patients, diagnostic clinical materials or data, or populations in any of the following areas: (1) disease mechanisms (etiopathogenesis); (2) bi-directional integrative (translational) research; (3) clinical knowledge, detection, diagnosis and natural history of disease; (4) therapeutic interventions including clinical trials of drugs, biologics, devices and instruments; (5) prevention (primary and secondary) and health promotion; (6) behavioral research; and (7) health services research, including outcomes, and cost-effectiveness.

Population Science

Epidemiology is the science that investigates the patterns, causes, and effects of health versus disease in populations or patient cohorts. This involves, but is not limited to: (1) quantification and control of morbidity and mortality; (2) high-throughput “omics” and deep DNA sequencing; (3) longitudinal observations; (4) natural experiments (Mendelian randomization); (5) validation of potential disease-causing mechanisms identified in experimental studies and generating hypotheses for mechanisms to be tested in experimental studies; (6) use of “big data”, registries and “eHealth platforms”; and (7) systems biology and pathway analysis for integrating clinical with molecular data.

Submitted manuscripts must not contain material previously published, except as an abstract, and must not be under consideration for publication elsewhere, in whole or in part. Manuscripts should conform to "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" (N Engl J Med. 1991; 324:424-428).

ORCID Linkage

As of January 1, 2020, all corresponding authors of article accepted to AHA Journals will be required to link an ORCID iD to their profile in the AHA Journal submission system.

ORCID (Open Researcher and Contributor Identifier) is an international, not-for-profit organization created for the benefit of researchers, research organizations, funders, and publishers. An ORCID iD is a 16-digit persistent digital identifier that distinguishes you from every other researcher. The AHA Journals will join other journal portfolios and grant funders (including the AHA and NIH) in enacting this requirement, which will disambiguate authors and will help authors maintain a persistent record of their publications.

To register with ORCID or link your profile to your ORCID iD, please go to “Modify Profile/Password” on the submission site homepage of any AHA Journal, and click the link in the “ORCID” section.

We encourage all authors to create and/or link their ORCID iD to their profile.

Initial Review Process

Submitted manuscripts will be evaluated initially by an associate editor or consulting editor. During initial review, the associate editor will determine whether the manuscript is appropriate for a full review based on the quality, originality, scientific rigor and data presentation/analysis of the manuscript. In some instances, the associate editor may reach out to a second reviewer (generally an assistant editor or invited reviewer with topic-related expertise) for a triage review. It is anticipated that approximately 50% of the submitted manuscripts will undergo formal review and 50% will be rejected without evaluation by external reviewers. This policy reflects the stringent requirements for the acceptance of manuscripts submitted to Stroke.

Expedited Publication

The editors invite submission of manuscripts that have major importance to the scientific community. To be considered for expedited publication, an article must be unique and contain information that could make a significant difference in medical practice or constitute an important advance in basic knowledge. The authors must clearly state reasons for the request in the cover letter. If the editors agree that an article should be an expedited publication, they will arrange an accelerated review and, if accepted, accelerated publication.

Consulting Editors

To avoid actual or perceived conflict of interest, the journal uses consulting editors to handle certain manuscripts. For more details, see the Conflict-of-Interest Procedures.

Cover Letter

Please upload a cover letter that includes the following statement: “All authors have read and approved the submitted manuscript, the manuscript has not been submitted elsewhere nor published elsewhere in whole or in part, except as an abstract (if relevant).” The authors may include the names of up to 3 reviewers whom they do not want to evaluate their submission. The editor ultimately decides who reviews the manuscript. Lastly, please note any potential overlapping content submitted or accepted to another journal or conference.

Instructions for Authors Menu

Article Types

Manuscript Preparation Instructions

Revised and Accepted Manuscripts

Forms

Submit Your Manuscript Now

  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭